Iria R.
- Country
- Spain
- Department
- Internal Medicine
Research Overview
Data & Insights
Has run more than one trial at 0 of 10 partner sites.
Specializations
Oncology – Advanced Solid Tumors
Concentrates on treatment‑resistant solid malignancies, especially hormone‑driven breast cancer and lung cancer subtypes.
- Hormone receptor‑positive breast cancer
- Non‑small cell lung cancer
- Renal cell carcinoma
Emphasis is placed on second‑line and later therapeutic options guided by molecular biomarkers.
Metabolic Liver Disease – NASH
Targets the progressive form of fatty liver disease characterized by steatosis, inflammation, and hepatocyte injury.
- Non‑alcoholic steatohepatitis
- Metabolic risk factors
- Liver fibrosis progression
Research aims to modify disease trajectory and prevent cirrhosis‑related complications.
Cardiovascular & Metabolic Risk
Focuses on atherosclerotic disease, heart failure phenotypes, and arrhythmic disorders linked to metabolic dysfunction.
- Atherosclerotic cardiovascular disease
- Heart failure with reduced ejection fraction
- Atrial fibrillation
Studies evaluate risk reduction strategies and novel therapeutic agents in high‑risk populations.
Autoimmune & Inflammatory Disorders
Investigates systemic and cutaneous autoimmune conditions with emphasis on disease activity control.
- Systemic lupus erythematosus
- Psoriatic arthritis
- Cutaneous lupus erythematosus
Therapeutic approaches aim to modulate immune pathways and improve quality of life.
Hematologic Malignancies
Addresses aggressive blood cancers, including acute and chronic forms, with a focus on novel targeted agents.
- Acute myeloid leukemia
- Multiple myeloma
- Non‑Hodgkin lymphoma
Efforts prioritize overcoming treatment resistance and extending survival.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.